Stay updated on Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer's ClinicalTrials.gov revision identifier is updated from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:17:39.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    - The study page now displays a 403 Forbidden error instead of the study details, blocking access to the trial information. This reflects a permissions issue on the page that prevents viewing the study record.
    Difference
    21%
    Check dated 2026-09-22T22:17:40.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Updated the study document revision from v3.6.6 to v3.7.0, signaling a newer version of the accompanying materials.
    Difference
    0.2%
    Check dated 2026-09-15T21:40:58.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The reported change set shows no additions or deletions, indicating the page remains unchanged in this update.
    Difference
    0.1%
    Check dated 2026-09-08T18:22:46.000Z thumbnail image
  7. Check
    45 days ago
    Change Detected
    Summary
    The study page shows a revision tag updated from v3.6.5 to v3.6.6, indicating a new version of the study documents. This is a small documentation update rather than a change to the study content or requirements.
    Difference
    0.2%
    Check dated 2026-09-01T18:17:30.000Z thumbnail image
  8. Check
    52 days ago
    Change Detected
    Summary
    No textual additions or deletions were provided to evaluate for this page.
    Difference
    0.2%
    Check dated 2026-08-25T19:37:16.000Z thumbnail image

Stay in the know with updates to Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.